Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D
Titel:
Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D
Auteur:
Yu, Evan Y. Ferrario, Cristiano Linch, Mark D. Stoeckle, Michael Laguerre, Brigitte Arranz, Jose A. Todenhöfer, Tilman Fong, Peter C. Piulats, Josep M. Berry, William Emmenegger, Urban Mourey, Loic Joshua, Anthony M. Mar, Nataliya Appleman, Leonard J. Conter, Henry J. Gravis, Gwenaelle Li, Xin Tong Schloss, Charles Poehlein, Christian de Bono, Johann S.
Verschenen in:
European urology oncology
Paginering:
Jaargang 8 () nr. 3 pagina's 641-651
Jaar:
2025
Inhoud:
Uitgever:
Merck Sharp and Dohme LLC., a subsidiary of Merck and Co., Inc., Rahway, NJ, USA., The Author(s)